von Hippel-Lindau disease predisposes patients to clear cell RCC, a highly vascular tumour type that frequently involves activation of the HIF pathway, an established regulator of VEGF and other angiogenic cytokines. The gene discussed is VEGFA; the disease is neoplasm.